Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04409015 · ClinicalTrials.gov registry record
ROTEM® Obstetric Hemorrhage Pilot Study
A clinical trial of High Risk Postpartum Hemorrhage (PPH), sponsored by Ohio State University.
- Completed
- Registry status
- 60
- Enrollment target
- 1
- Study location
NCT04409015 is a study of High Risk Postpartum Hemorrhage (PPH) that has completed, run by Ohio State University. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04409015, a study of High Risk Postpartum Hemorrhage (PPH), has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor \&Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.
Conditions Studied
Interventions
- DEVICE ROTEM - rotation thromboelastometry testing
Study Locations (1)
Ohio
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal Medicine - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2020-07-27 |
| Est. Completion | 2022-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04409015
The ClinicalTrials.gov registry entry for NCT04409015 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with High Risk Postpartum Hemorrhage (PPH) appearing as the primary indexed condition, and to 1 intervention - of which ROTEM - rotation thromboelastometry testing is the first listed.
NCT04409015 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04409015 about?
NCT04409015 is a clinical study titled "ROTEM® Obstetric Hemorrhage Pilot Study". This is a prospective observational study among women at high-risk of postpartum hemorrhage, in their third trimester who are admitted to Labor \&Delivery in spontaneous labor, for induction of labor, or for scheduled cesarean section.
What is the current status of trial NCT04409015?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2020-07-27. Estimated completion is 2022-03-01.
What conditions does trial NCT04409015 study?
This clinical trial studies the following conditions: High Risk Postpartum Hemorrhage (PPH).
What interventions are being tested in trial NCT04409015?
The interventions under investigation include: ROTEM - rotation thromboelastometry testing (DEVICE).
Who is sponsoring clinical trial NCT04409015?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04409015 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.